SEC Form 4/A · accession 0001193125-26-268606
TREACE MEDICAL CONCEPTS, INC. · TMCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John T. Treace
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 9:26 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001630627
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 10, 2026 | P | 14,715 | $4.024 | A | 7,338,548 | D | |
| Common StockF4,F5,F3 | Jun 11, 2026 | P | 9,891 | $4.0423 | A | 7,348,439 | D | |
| Common StockF6 | holding | — | — | — | 1,605,000 | I | By spouse | |
| Common StockF6 | holding | — | — | — | 1,471,250 | I | By spouse as trustee of a trust | |
| Common StockF7 | holding | — | — | — | 1,839,063 | I | As trustee of a trust | |
| Common StockF7 | holding | — | — | — | 408,816 | I | As co-trustee of a trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 10, 2026 as a total of 29,430 shares purchased when in fact 14,715 shares of the Issuer's common stock were purchased.
- F2The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F3Includes 542,784 restricted stock units.
- F4The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 11, 2026 as a total of 22,887 shares purchased when in fact 9,891 shares of the Issuer's common stock were purchased.
- F5The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F6The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- F7The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.